The OSU Center for Clinical and Translational Science: Advancing Today's Discoveries to Improve Health
俄勒冈州立大学临床和转化科学中心:推进当今的发现以改善健康
基本信息
- 批准号:10705933
- 负责人:
- 金额:$ 562.3万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2023
- 资助国家:美国
- 起止时间:2023-08-22 至 2030-07-31
- 项目状态:未结题
- 来源:
- 关键词:AddressAdoptedAppalachian RegionApplied ResearchCOVID-19ClinicalClinical ResearchClinical SciencesClinical and Translational Science AwardsCollaborationsCommunitiesDataData ScienceData SetDecision MakingDemocracyDevelopmentDisciplineDisparityDissemination and ImplementationEducationEffectivenessEnsureEnvironmentEquityFacultyFoundationsFundingGrantGrowthHealthHealthcareHumanIndividualIndustryInfantInfrastructureInstitutionInvestmentsKnowledgeLeadershipLeftLife Cycle StagesMaternal MortalityMedical centerMethodsOhioOutcomes ResearchPatientsPediatric HospitalsPopulationProcessPublic HealthRacial injusticeReach, Effectiveness, Adoption, Implementation, and MaintenanceResearchResearch DesignResearch PersonnelResource InformaticsResourcesRuralScienceSystemSystems IntegrationThinkingTrainingTraining SupportTraining and EducationTranslational ResearchUniversitiesValidationVisionVoiceWorkcareer developmentclinical centerclinical translationclinically relevantcollegecommunity engaged researchcomplex datacomputing resourcescostdata accessdemographicshealth care deliveryhealth disparityhealth equityimplementation scienceimprovedinnovationlensmembermulti-site trialnovel strategiesopioid epidemicresponseskillssocialsocial health determinantstooltranslational pipeline
项目摘要
ABTRACT
The Ohio State University (OSU) Center for Clinical and Translational Science (CCTS) was formed in 2007,
with the vision to advance today’s discoveries to improve health for all. We employed a comprehensive
approach to address the full spectrum of T1-T4 science via the education and career development of a highly
trained workforce integrated with a robust system of CTR resources. We provided leadership in the CTSA
Consortium through sharing of tools and methods to advance CTR; adopted innovations from other hubs; and
fully engaged in CTSA Consortium activities (e.g., multisite trials). We also supported community engaged
research addressing the most pressing health issues in our communities (e.g., opioid crisis, COVID-19). Yet,
work remains. Thus, we build upon unique strengths at OSU/NCH and in Ohio’s communities. We have
leveraged our strategic investment in data sciences, a robust environment of resources, and a vibrant CTR
community to address CTS gaps and barriers. We will now address five CTS roadblocks to improve the
quality, efficiency, and rigor of CTR: (1) need for improved efficiencies and effectiveness to advance CTR and
ensure results are disseminated and implemented into healthcare; 2) education and training innovations do not
reach the full CTR workforce, resulting in a declining and inadequately diverse CTS workforce, lacking the
knowledge and skills to advance CTR; 3) limited authentic participation by diverse stakeholders across the
research life cycle; 4) growth of complex datasets necessitates integration of clinical, environmental, and
research data, with need for democratization of data accessibility to advance data equity; and 5) racial injustice,
SDoH, the CTR teams we form, and interpretation of our results impact health disparities. Applying a health
equity and DEIA framework to every activity, we will pursue five aims: Aim 1: Develop innovations in
methods, approaches, and tools to address pressing roadblocks facing CTR. Aim 2: Support training and
career development of the full CTS workforce. Aim 3: Engage voices from across academic and scientific
disciplines, patients, communities, and industry to conduct CTR and CTS across the full lifecycle of the scientific
process. Aim 4: Deploy an accessible, responsive, and integrated system of research resources. Aim 5:
Democratize informatics resources by lowering the cost of entry for data access and computing resources. With
a commitment to metric-driven decision-making, we will evaluate the impact of the CCTS by applying the RE-
AIM framework to inform strategic pivots over the next 7 years. This proposal reaffirms our commitment to
advance CTS and expands our engagement with stakeholders to increase rigorous, impactful, and relevant
CTR. We will develop, share, and adopt innovations through focused CTS to enhance CTR for the communities
we serve and those we engage. These resources, skilled workforce, and institutional strengths provide an agile
foundation to facilitate rapid responses to emerging public health issues, and will ensure an equity lens is
applied to all CTR so no one is left behind from the advances of CTR to improve human health.
添加
俄亥俄州立大学(OSU)临床与转化科学中心(CCTS)于2007年成立
愿意提高当今发现以改善所有人的健康。我们采用全面的
通过高度的教育和职业发展来解决T1-T4科学的全部范围的方法
经过培训的劳动力与强大的CTR资源系统集成在一起。我们在CTSA中提供了领导
通过共享工具和方法来推进CTR的财团;采用其他枢纽的创新;和
完全从事CTSA联盟活动(例如,多站点试验)。我们还支持社区参与
研究解决社区中最紧迫的健康问题的研究(例如,阿片类药物危机,Covid-19)。然而,
工作仍然存在。这是我们在OSU/NCH和俄亥俄州社区的独特优势的基础。我们有
利用我们在数据科学,强大的资源环境和充满活力的CTR上利用我们的战略投资
解决CTS差距和障碍的社区。现在,我们将向五个CTS障碍介绍以改进
CTR的质量,效率和严格:(1)需要提高效率和有效性以提高CTR和CTR
确保结果被传播并实施到医疗保健中; 2)教育和培训创新没有
到达全部CTR劳动力,导致CTS劳动力的下降和不足的劳动力缺乏
促进CTR的知识和技能; 3)各种利益相关者的真实参与有限
研究生命周期; 4)复杂数据集的增长必要的临床,环境和环境的整合
研究数据,需要民主化数据可访问性以提高数据权益; 5)种族伤害,
SDOH,我们组成的CTR团队,对结果的解释会影响健康差异。应用健康
对每项活动的公平和DEIA框架,我们将追求五个目标:目标1:发展创新
解决CTR面向的压障碍的方法,方法和工具。目标2:支持培训和
全CTS劳动力的职业发展。目标3:跨学术和科学的声音
学科,患者,社区和行业在科学的整个生命周期内进行CTR和CTS
过程。目标4:部署可访问,响应且集成的研究资源系统。目标5:
通过降低数据访问和计算资源的进入成本来使信息资源民主化。和
我们对以公制驱动的决策做出的承诺,我们将通过应用重新来评估CCT的影响
目标框架在未来7年内为战略枢纽提供信息。该提案重申了我们对
提高CTS并扩大我们与利益相关者的参与,以增加严格,有影响力和相关性
CTR。我们将通过重点CTS开发,共享和采用创新,以增强社区的CTR
我们服务和我们参与的人。这些资源,熟练的劳动力和机构优势提供了敏捷
促进对新兴公共卫生问题的快速回应的基础,并将确保股权镜头是
适用于所有CTR,因此CTR的进步没有人抛弃以改善人类健康。
项目成果
期刊论文数量(3)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
Social Media Use and Its Concurrent and Subsequent Relation to a Biological Marker of Inflammation: Short-Term Longitudinal Study.
- DOI:10.2196/46309
- 发表时间:2023-12-08
- 期刊:
- 影响因子:7.4
- 作者:Lee, David;Jiang, Tao;Crocker, Jennifer;Way, Baldwin
- 通讯作者:Way, Baldwin
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
CYNTHIA A GERHARDT其他文献
CYNTHIA A GERHARDT的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('CYNTHIA A GERHARDT', 18)}}的其他基金
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10524167 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Moderating Role of Sibling Relationships (Diversity Supplement for D. Garcia)
早发儿科癌症年轻幸存者的心理社会风险:兄弟姐妹关系的调节作用(D. Garcia 的多样性补充)
- 批准号:
10381330 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10348200 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10737753 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10771642 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Moderating Role of Residential Location (Diversity Supplement for V. Patterson)
早发儿科癌症年轻幸存者的心理社会风险:居住地点的调节作用(V. Patterson 的多样性补充)
- 批准号:
10382011 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10524166 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects
早发儿科癌症年轻幸存者的心理社会风险:身体和神经认知迟发效应的作用
- 批准号:
10608131 - 财政年份:2021
- 资助金额:
$ 562.3万 - 项目类别:
Sibling and Parent Bereavement from Childhood Cancer
因儿童癌症而失去兄弟姐妹和父母
- 批准号:
6973660 - 财政年份:2005
- 资助金额:
$ 562.3万 - 项目类别:
Sibling and Parent Bereavement from Childhood Cancer
因儿童癌症而失去兄弟姐妹和父母
- 批准号:
7618250 - 财政年份:2005
- 资助金额:
$ 562.3万 - 项目类别:
相似国自然基金
采用新型视觉-电刺激配对范式长期、特异性改变成年期动物视觉系统功能可塑性
- 批准号:32371047
- 批准年份:2023
- 资助金额:50 万元
- 项目类别:面上项目
破解老年人数字鸿沟:老年人采用数字技术的决策过程、客观障碍和应对策略
- 批准号:72303205
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
通过抑制流体运动和采用双能谱方法来改进烧蚀速率测量的研究
- 批准号:12305261
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
采用多种稀疏自注意力机制的Transformer隧道衬砌裂缝检测方法研究
- 批准号:62301339
- 批准年份:2023
- 资助金额:30.00 万元
- 项目类别:青年科学基金项目
政策激励、信息传递与农户屋顶光伏技术采用提升机制研究
- 批准号:72304103
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
相似海外基金
Social and biological determinants of pregnancy-related mortality and morbidity among rural, underserved women
农村、服务不足的妇女中妊娠相关死亡率和发病率的社会和生物决定因素
- 批准号:
10066601 - 财政年份:2020
- 资助金额:
$ 562.3万 - 项目类别:
Social and biological determinants of pregnancy-related mortality and morbidity among rural, underserved women
农村、服务不足的妇女中妊娠相关死亡率和发病率的社会和生物决定因素
- 批准号:
10676160 - 财政年份:2020
- 资助金额:
$ 562.3万 - 项目类别:
Social and biological determinants of pregnancy-related mortality and morbidity among rural, underserved women
农村、服务不足的妇女中妊娠相关死亡率和发病率的社会和生物决定因素
- 批准号:
10461098 - 财政年份:2020
- 资助金额:
$ 562.3万 - 项目类别:
Appalachian Center for Cellular transport in Obesity Related Disorders (ACCORD) Genomics and Bioinformatics Core
阿巴拉契亚肥胖相关疾病细胞运输中心 (ACCORD) 基因组学和生物信息学核心
- 批准号:
10460403 - 财政年份:2018
- 资助金额:
$ 562.3万 - 项目类别: